FDA Approves Aqneursa for Ataxia-Telangiectasia
FDA expanded Aqneursa, levacetylleucine, to treat ataxia in adults and children with ataxia-telangiectasia who weigh at least 15 kilograms. It is the first approved treatment for the neurologic manifestation of this rare ATM-deficiency disorder….
